Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 1/20 | 0.38 |
| ▸ | CA12 | O43570 | 1/20 | 0.37 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.37 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.37 |
| ▸ | CA1 | P00915 | 1/20 | 0.36 |
| ▸ | CA2 | P00918 | 1/20 | 0.36 |
| ▸ | CA7 | P43166 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.36 |
| ▸ | NOS1 | P29475 | 2/20 | 0.35 |
| ▸ | NOS3 | P29474 | 1/20 | 0.35 |
| ▸ | NOS2 | P35228 | 1/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.32 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.32 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.32 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.32 |
| ▸ | APP | P05067 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1953733 | 1.00 | TP53 (0.38) | TP53CA12CA14DGAT1CA1 | |
| SCHEMBL1332536 | 1.00 | TP53 (0.38) | TP53CA12CA14DGAT1CA1 | |
| Alcohol SCHEMBL8207414 | 0.91 | CA1 (0.36) | TP53CA12CA14DGAT1CA1 | |
| Propionic Acid SCHEMBL3457303 | 0.87 | FFAR3 (0.42) | TP53CA12CA14CA1CA2 | |
| SCHEMBL7260792 | 0.84 | CA12 (0.33) | TP53CA12CA14DGAT1CA1 | |
| SCHEMBL8030378 | 0.82 | HTT (0.40) | CA12CA14DGAT1CA1CA2 | |
| SCHEMBL19407016 | 0.82 | HTT (0.40) | CA12CA14DGAT1CA1CA2 | |
| SCHEMBL8028869 | 0.82 | HTT (0.40) | CA12CA14DGAT1CA1CA2 | |
| SCHEMBL1845280 | 0.82 | HTT (0.40) | CA12CA14DGAT1CA1CA2 | |
| SCHEMBL11855010 | 0.81 | CA1 (0.39) | CA12CA14DGAT1CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 738 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260144726-A1 | POLYOL-FREE COSMETIC COMPOSITION COMPRISING ALPHA HYDROXY ACID ESTER | L'OREAL (FR) | 2026-05-28 | — | — | US | claimed |
| US-12428301-B1 | Graphene composition | ROCKHILL ALVIN T (US) | 2025-09-30 | — | — | US | claimed |
| CN-119529249-A | Method for producing polylactic acid-glycolic acid copolymer, and polylactic acid-glycolic acid copolymer produced by said method | 中国石油大学(华东) | 2025-02-28 | — | — | CN | claimed |
| CN-119350291-A | Six-membered oxygen heterocyclic lactone, degradable polyether ester and preparation and degradation methods thereof | 青岛科技大学 | 2025-01-24 | — | — | CN | claimed |
| WO-2024262810-A1 | METHOD FOR PREPARING DOUBLE-LAYER HALIDE PEROVSKITE FILM USING ECO-FRIENDLY SOLVENT, PEROVSKITE FILM PREPARED THEREBY AND ENERGY HARVESTING DEVICE COMPRISING SAME | 한양대학교 산학협력단 | 2024-12-26 | — | — | WO | claimed |
| US-20240360312-A1 | PURIFICATION METHODS FOR MODIFIED ROSIN COMPOSITIONS | MAINSTREAM PINE PRODUCTS, LLC | 2024-10-31 | — | — | US | claimed |
| CN-117126383-A | Method for preparing high molecular weight polylactic acid | 中国石油大学(华东) | 2023-11-28 | — | — | CN | claimed |
| WO-2023222042-A1 | MANUFACTURING METHOD FOR HIGH-MOLECULAR-WEIGHT POLYLACTIC ACID | 中国石油大学(华东) | 2023-11-23 | — | — | WO | claimed |
| CN-112675311-B | 18/19 F-labeled PSMA (PSMA-conjugated diene monomer) targeting diagnosis and treatment integrated small-molecule drug conjugate, and preparation method and application thereof | 西安交通大学医学院第一附属医院 | 2023-06-20 | — | — | CN | claimed |
| WO-2022261278-A1 | PURIFICATION METHODS FOR MODIFIED ROSIN COMPOSITIONS | INGEVITY SOUTH CAROLINA, LLC (US) | 2022-12-15 | — | — | WO | claimed |
| US-7081248-B2 | Concentrated water-dispersible vitamin compositions | ADISSEO FRANCE S.A.S. (FR) | 2006-07-25 | — | — | US | claimed |
| US-20060110415-A1 | Topical Delivery System for Cosmetic and Pharmaceutical Agents | BIODERM RESEARCH (US) | 2006-05-25 | — | — | US | claimed |
| CN-1242303-C | Agent for lowering dependence of substrate | WAKO PURE CHEM IND LTD (JP) | 2006-02-15 | — | — | CN | claimed |
| CN-1278076-A | Agent for lowering dependence of substrate | WAKO PURE CHEM IND LTD (JP) | 2000-12-27 | — | — | CN | claimed |
| EP-1059563-A1 | Agent for reducing substrate dependence of resist | Wako Pure Chemical Industries, Ltd. (JP) | 2000-12-13 | — | — | EP | claimed |
| EP-0150914-B1 | SKIN TREATMENT COMPOSITION | UNILEVER N.V. (NL) | 1991-05-22 | — | — | EP | claimed |
| US-4772592-A | Skin treatment composition | LEVER BROTHERS COMPANY (US) | 1988-09-20 | — | — | US | claimed |
| EP-0058474-B1 | COSMETIC PRODUCT | UNILEVER PLC (GB) | 1986-01-02 | — | — | EP | claimed |
| EP-0150914-A2 | Skin treatment composition | UNILEVER N.V. (NL) | 1985-08-07 | — | — | EP | claimed |
| EP-0058474-A2 | Cosmetic product | UNILEVER PLC (GB) | 1982-08-25 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260144726-A1 | POLYOL-FREE COSMETIC COMPOSITION COMPRISING ALPHA HYDROXY ACID ESTER | HAO2, HADH, LDHA | TP53 598/4885CA12 292/4885CA14 266/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.